文献速递细菌感染、耐药与抗菌药物病毒性肝炎艾滋病与性传播感染

2007-2017年美国18-64岁HIV、HCV感染或阿片类使用障碍者中的感染性心内膜炎

Infective Endocarditis Among Persons Aged 18-64 Years Living with Human Immunodeficiency Virus, Hepatitis C Infection, or Opioid Use Disorder, United States, 2007-2017.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该回顾性队列分析基于商业保险和医疗补助数据库,估计2017年美国HIV、HCV感染及阿片类使用障碍(OUD)人群中感染性心内膜炎(IE)发病率,并计算2007-2017年商业保险人群的年百分比变化。结果显示商业保险人群IE加权发病率为13.8/10万,医疗补助人群为78.7/10万;HCV或OUD的年轻人群IE发病率大幅上升。

要点

  • 2017年IE加权发病率:商业保险13.8/10万,医疗补助78.7/10万。
  • 商业保险HIV感染者IE发病率从2007年148.0降至2017年112.1(EAPC -4.3%)。
  • 18-29岁HCV感染者IE发病率从322.3升至1007.1(EAPC 16.3%),OUD者从156.4升至642.9(EAPC 14.8%)。

核心结论

  • HCV感染或OUD的年轻人群中IE发病率显著上升,与全国阿片危机平行。

研究设计与样本

  • 回顾性队列分析,使用商业保险和医疗补助数据库估计2017年美国IE发病例数,按HIV、HCV、OUD分层,并计算2007-2017年商业保险人群EAPC。

主要发现

  • 商业保险人群IE加权发病率为13.8/10万,医疗补助人群为78.7/10万。
  • 商业保险人群IE发病率2007-2017年轻微上升(EAPC 1.0%)。
  • 商业保险HIV感染者IE发病率从2007年148.0降至2017年112.1(EAPC -4.3%)。
  • 商业保险HCV感染者IE发病率从2007年172.4升至2017年238.6(EAPC 3.2%)。
  • 18-29岁HCV感染者IE发病率从2007年322.3升至2017年1007.1(EAPC 16.3%),OUD者从156.4升至642.9(EAPC 14.8%)。

临床怎么用

  • 对年轻HCV感染者或OUD者应警惕IE,并加强减害服务、阿片类使用障碍药物治疗和安全注射实践以预防HIV、HCV和IE传播。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infective endocarditis (IE) is a life-threatening bacterial infection of the heart valves, most often diagnosed in older persons and persons with prior cardiac surgery. It is also associated with injection drug use, a behavior that has increased in recent years along with the US opioid crisis. METHODS: We conducted a retrospective cohort analysis of commercial and Medicaid health insurance databases to estimate incident cases of IE in the United States in 2017, stratified by persons living with human immunodeficiency virus (HIV), hepatitis C virus (HCV), and opioid use disorder (OUD). We also estimated annual percentage changes (EAPCs) in IE from 2007-2017 among persons with commercial insurance. RESULTS: The weighted incidence rate of IE was 13.8 cases per 100 000 persons among persons with commercial insurance, and 78.7 among those with Medicaid. The incidence rate of IE among commercially insured persons increased slightly from 2007-2017 (EAPC, 1.0%). It decreased among commercially insured persons living with HIV, from 148.0 in 2007 to 112.1 in 2017 (EAPC, -4.3%), and increased among those with HCV infection, from 172.4 in 2007 to 238.6 in 2017 (EAPC, 3.2%). Among persons aged 18-29 years with HCV infection, IE increased from 322.3 in 2007 to 1007.1 in 2017 (EAPC, 16.3%), and among those with OUD it increased from 156.4 in 2007 to 642.9 in 2017 (EAPC, 14.8%). CONCLUSIONS: The incidence rate of IE increased markedly among young persons with HCV infections or OUD. This increase appears to parallel the ongoing national opioid crisis. Harm reduction with syringe services programs, medications for opioid use disorder, and safe injection practices can prevent the spread of HIV, HCV, and IE.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wong CY, Zhu W, Aurigemma GP, et al. Infective Endocarditis Among Persons Aged 18-64 Years Living with Human Immunodeficiency Virus, Hepatitis C Infection, or Opioid Use Disorder, United States, 2007-2017. Clin Infect Dis. 2021. PMID: 32270861. doi:10.1093/cid/ciaa372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。